Results for this period
Third quarter21 May 2025 to 20 February 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Improved pharmacy attachment rate, expansion of the food category, including fresh foods, opening of 71 drugstores and 35 pharmacies, and the consolidation of 株式会社ミワ商店 as a subsidiary. Share-based compensation expense of ¥392 million recorded in the same period of the previous year was not recorded in the current period.
None ("There are no applicable matters.")
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 21 May 2025 to 20 February 2026 |
| Net Sales | ¥422,807 million (YoY +13.7%) |
| Operating profit | ¥21,420 million (YoY +7.4%) |
| Ordinary income | ¥21,835 million (YoY +6.6%) |
| Profit attributable to owners of the parent | ¥15,376 million (YoY +10.3%) |
| Net income per share | ¥157.82 |
| Equity ratio | End of the current fiscal period 35.7 / End of previous period 41.4 |
| Total assets | ¥388,578 million |
| Net assets | ¥138,742 million |
| Full-year earnings forecast | Net Sales ¥560,000 million (YoY +11.7%) / Operating profit ¥23,000 million (YoY -13.5%) / Ordinary income ¥22,700 million (YoY -17.5%) / Net income ¥15,500 million (YoY -12.9%) |
| Revision to Earnings Forecast | Not disclosed → Not disclosed |
| Annual Dividend Forecast | ¥14 → ¥56(+300.0%) |
| Regional sales | data 170,840 (YoY +6.8%), 35,150 (YoY +34.9%), 98,737 (YoY +12.1%), 66,597 (YoY +9.5%), 37,558 (YoY +27.3%), 13,922 (YoY +88.2%) |
| Depreciation and amortization | ¥10,533 million |
| Impairment loss | ¥107 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥57 million, Gain on sale of investment securities ¥15 million / Extraordinary loss Loss on sale of fixed assets ¥1 million, Loss on Disposal of Fixed Assets ¥191 million, Impairment Losses ¥107 million |
| Disclosure regarding the going concern assumption | None ("There are no applicable matters.") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 1 / Company name 株式会社ミワ商店 / Excluded Number of companies 0 / Company name Not disclosed / Cover page Significant changes in the scope of consolidation during the cumulative consolidated third-quarter period: No |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 95,616,980 Shares |
| Treasury Shares at Period-End | 653,913 Shares |
| Factors Behind Changes in Business Performance | Improved pharmacy attachment rate, expansion of the food category, including fresh foods, opening of 71 drugstores and 35 pharmacies, and the consolidation of 株式会社ミワ商店 as a subsidiary. Share-based compensation expense of ¥392 million recorded in the same period of the previous year was not recorded in the current period. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company raised its pharmacy attachment rate, expanded its food category, including fresh foods, opened 71 drugstores and 35 pharmacies, and made 株式会社ミワ商店 a consolidated subsidiary. It also identified as a factor in the increase in profit the fact that share-based compensation expense of ¥392 million recorded in the same period of the previous year was not recorded in the current period.